Doctor profile · Federal record
Dr. Sara Huff, MD
Dermatology Physician (CMS: Dermatology) · Westerville, OH
- NPI 1386147197
- Accepts Medicare
- MIPS 97.9 / 100 · 2023
- 8 yrs in practice
- Female
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
430 Altair Pkwy Ste 210
Westerville, OH 430827647
(614) 898-7546
Credentials & registration
- NPI registered
- March 2018 — 8 yrs on file
- Profile last updated
- December 9, 2025
- Year of graduation
- 2018 — 8 yrs since
- Specialty taxonomy
- 207N00000X — NUCC code
- State license (1)
- Ohio #35.145413
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1386147197. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
2,514
Distinct HCPCS
10
Medicare allowed
$158,540
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
17003 |
Destruction of precancer skin growth, 2-14 growths | 791 | 209 | $6 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 411 | 342 | $86 | |
17000 |
Destruction of precancer skin growth, 1 growth | 397 | 317 | $55 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 149 | 120 | $122 | |
11102 |
Biopsy of related skin growth, first growth | 146 | 135 | $88 | |
99212 |
Established patient office or other outpatient visit, 10-19 minutes | 107 | 100 | $54 | |
17110 |
Destruction of skin growth, 1-14 growths | 97 | 78 | $100 | |
99203 |
New patient office or other outpatient visit, 30-44 minutes | 83 | 83 | $105 | |
J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 55 | 14 | $1 | |
99202 |
New patient office or other outpatient visit, 15-29 minutes | 45 | 45 | $67 |
In context: peer comparison
Among 12 peers in Westerville Dermatology Physician, average services per provider: 131. This provider delivers 19× the peer median.Open Payments
Industry payments received
All-time total
$1,442
Transactions
80
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Janssen Biotech, INC. | 14 | $282.44 | |
| Abbvie INC. | 22 | $238.59 | |
| Incyte Corporation | 17 | $188.53 | |
| E.R. Squibb & Sons, L.L.C. | 2 | $131.79 | |
| Regeneron Healthcare Solutions, INC. | 3 | $79.82 | |
| Leo Pharma INC. | 4 | $71.55 | |
| Amgen INC. | 4 | $70.11 | |
| Genzyme Corporation | 2 | $39.82 | |
| Verrica Pharmaceuticals INC. | 2 | $38.80 | |
| Novartis Pharmaceuticals Corporation | 2 | $38.38 | |
| Pfizer INC. | 2 | $34.79 | |
| Sun Pharmaceutical Industries INC. | 2 | $34.45 | |
| Lilly USA, LLC | 2 | $31.31 | |
| Organogenesis INC. | 1 | $29.67 | |
| Krystal Biotech INC | 1 | $25.87 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
716
Patients
456
Total drug cost
$273,853
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Fluorouracil | Generic | 142 | 123 | $12,035 |
| Clobetasol Propionate | Generic | 108 | 68 | $6,202 |
| Ketoconazole | Generic | 103 | 72 | $2,875 |
| Triamcinolone Acetonide | Generic | 101 | 82 | $1,428 |
| Hydrocortisone | Generic | 60 | 45 | $478 |
| Doxycycline Hyclate | Generic | 48 | 29 | $1,706 |
| Dupixent Pen (Dupilumab) | Brand | 37 | 0 | $152,137 |
| Metronidazole | Generic | 24 | 14 | $1,362 |
| Clindamycin Phosphate | Generic | 18 | 12 | $1,101 |
| Betamethasone Dipropionate | Generic | 14 | 0 | $463 |
Frequently asked questions
What is Dr. Sara Huff's medical specialty?
Dr. Sara Huff practices Dermatology Physician in Westerville, OH.
Where does Dr. Sara Huff practice?
Dr. Sara Huff practices at 430 Altair Pkwy Ste 210, Westerville, OH 430827647. Office phone: 6148987546.
What is Dr. Sara Huff's NPI?
Dr. Sara Huff's National Provider Identifier (NPI) is 1386147197, issued by NPPES.
Does Dr. Sara Huff accept Medicare assignment?
Yes. Dr. Sara Huff accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Sara Huff commonly perform?
Top Medicare-reported procedures in 2023: Destruction of precancer skin growth, 2-14 growths (HCPCS 17003); Established patient office or other outpatient visit (HCPCS 99213); Destruction of precancer skin growth, 1 growth (HCPCS 17000). Source: CMS Medicare Physician & Other Practitioners file.